Frontotemporal Dementia

Frontotemporal dementia (FTD) refers to disorders caused by progressive neuronal loss in the frontal and temporal lobes of the brain. Here is the latest research on FTD and FTD-associated disorders.

January 17, 2021

Modelling the cascade of biomarker changes in GRN -related frontotemporal dementia

Journal of Neurology, Neurosurgery, and Psychiatry
Jessica L PanmanGENFI consortium investigators
January 16, 2021
Review

FUS and TDP-43 Phases in Health and Disease

Trends in Biochemical Sciences
Bede PortzJames Shorter
January 18, 2021
Open Access

Clearance of intracellular tau protein from neuronal cells via VAMP8-induced secretion

The Journal of Biological Chemistry
Julie PilliodNicole Leclerc
January 13, 2021

Clinical and Neuroimaging Aspects of Familial Frontotemporal Lobar Degeneration Associated with MAPT and GRN Mutations

Advances in Experimental Medicine and Biology
Bradley F Boeve, Howard Rosen
January 19, 2021

The cognitive aspect of formal thought disorder and its relationship with global social functioning and the quality of life of in schizophrenia

Social Psychiatry and Psychiatric Epidemiology
Emre MutluA Elif Anıl Yağcıoğlu
January 19, 2021

Improving the Diagnosis of the Frontal Variant of Alzheimer's Disease with the DAPHNE Scale

Journal of Alzheimer's Disease : JAD
Elsa LehingueClaire Boutoleau-Bretonnière
January 13, 2021

Measuring Behavior and Social Cognition in FTLD

Advances in Experimental Medicine and Biology
Katherine P Rankin
January 13, 2021

Trends in Understanding the Pathological Roles of TDP-43 and FUS Proteins

Advances in Experimental Medicine and Biology
Emanuele Buratti
January 14, 2021
Open Access

An MRI-based strategy for differentiation of frontotemporal dementia and Alzheimer's disease

Alzheimer's Research & Therapy
Qun YuFrontotemporal Lobar Degeneration Neuroimaging Initiative
January 18, 2021
Open Access

FUS contributes to mTOR-dependent inhibition of translation

The Journal of Biological Chemistry
Myriam SévignyChantelle F Sephton
January 13, 2021
Preprint
Open Access

Proton magnetic resonance spectroscopy in frontotemporal lobar degeneration-related syndromes

MedRxiv : the Preprint Server for Health Sciences
Alexander G MurleyJ. B. Rowe
January 15, 2021
Open Access

Repeatability of Commonly Used Speech and Language Features for Clinical Applications

Digital Biomarkers
Gabriela M StegmannVisar Berisha
January 13, 2021

A Multi-omics Data Resource for Frontotemporal Dementia Research

Advances in Experimental Medicine and Biology
Peter HeutinkAnupriya Dalmia
January 13, 2021

Behavioural Variant Frontotemporal Dementia: Recent Advances in the Diagnosis and Understanding of the Disorder

Advances in Experimental Medicine and Biology
Rebekah M AhmedOlivier Piguet
January 13, 2021

Fluid Biomarkers of Frontotemporal Lobar Degeneration

Advances in Experimental Medicine and Biology
Emma L van der Ende, John C Van Swieten
January 19, 2021
Preprint
Open Access

Cholinergic signalling in the forebrain controls microglial phenotype and responses to systemic inflammation

BioRxiv : the Preprint Server for Biology
A. NazmiColm Cunningham

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/frontotemporal-dementia/806b2e01-8987-48ff-a599-f71effb4d394